EXELIXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.12 USD | +0.62% |
|
-2.18% | -11.96% |
| 14/05 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
| 10/05 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
5e4ae85.pg0efK0FKnNWBBMmNm0WTqM6io-DsaELuY_TOXP4l68.7GktPehTYxoPfFRlDlRMdvd71cPE9_Fujem8axyc0NvMfi0o-W5jKTo8Jw~108bfe8f1ebf8e36677173fda64fea16